http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109432444-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd37b53f7a639daf413b490204ba4613
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-52
filingDate 2018-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e084fce200adfc0df71b9fc239ae5dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f506ea6fda665e61714df4b3822516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82291e4dced97d21908939cee7aae68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e87a02fdca5963a18b156169c27be9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91cc2c0034cc9027c0a3eeb96558bf22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad06e9d6edda2c2535e6191ea083858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2cb6e1ea15727a54b966927902107cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42d99000adeea13dc7b6dcf9810a85d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acce8546f0817035b5cf22e72b20d929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae62d552b7f2e99755dbaaa9b886550
publicationDate 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109432444-A
titleOfInvention Method for preparing traceable antitumor drug based on carbon dots and medicament thereof
abstract The invention discloses a preparation method of a traceable anti-tumor drug based on a carbon dot and a medicament thereof, and the specific steps are as follows: Step 1: mixing a carbon point with a CPT ethanol solution to obtain a first mixed solution, and then to the first mixture An ethanol solution is added to the solution and stirred. After the stirring is completed, the supernatant is separated and the supernatant is separated to obtain a solid substance. The solid substance is washed with ethanol, added to the second mixed solution, and dried in an oven to obtain a solid powder. It is the finished product. The invention combines the anticancer drug camptothecin on the carbon spot, and successfully obtains a "carbon point-anticancer drug" complex with good water solubility and high drug loading rate, and the "carbon point-anticancer drug" complex has The killing efficiency of cancer cells is high and traceable.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113548656-A
priorityDate 2018-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108226074-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453001630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451620691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447749352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 55.